p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones
- 15 August 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (16), 4400-4404
- https://doi.org/10.1016/j.bmcl.2006.05.045
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificityNature Structural & Molecular Biology, 2003
- p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffoldBioorganic & Medicinal Chemistry Letters, 2003
- Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinaseBioorganic & Medicinal Chemistry Letters, 2003
- THE PREPARATION OF 5-FLUORONICOTINIC ACID AND 5-FLUORONICOTINAMIDE1The Journal of Organic Chemistry, 1949